Mature results of a randomized trial comparing two fractionation schedules of high dose rate endoluminal brachytherapy for the treatment of endobronchial tumors

Radiation Oncology

Volumn 8, Issue 1, 2013, Pages

  Niemoeller, Olivier M ^a   Pöllinger, Barbara ^a   Niyazi, Maximilian ^a   Corradini, Stefanie ^a   Manapov, Farkhad ^a   Belka, Claus ^a   Huber, Rudolf M ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Endobronchial radiotherapy; High dose rate brachytherapy; Lung cancer; Re irradiation

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; BLEEDING; BRACHYTHERAPY; BRONCHUS TUMOR; CANCER CONTROL; CANCER STAGING; FEMALE; GENDER; HISTOPATHOLOGY; HUMAN; KARNOFSKY PERFORMANCE STATUS; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PALLIATIVE THERAPY; PROGNOSIS; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RISK ASSESSMENT; SCORING SYSTEM; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BRACHYTHERAPY; BRONCHIAL NEOPLASMS; CARCINOMA, LARGE CELL; CARCINOMA, SQUAMOUS CELL; DOSE FRACTIONATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84871853187     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-8-8     Document Type: Article

References (25)

1. Jemal A, Siegel R, Ward E, Hao YP, Xu JQ, Murray T, Thun MJ. Cancer statistics, 2008. CA Cancer J Clin 2008, 58:71-96. 10.3322/CA.2007.0010, 18287387.
2. Goeckenjan G, Sitter H, Thomas M, Branscheid D, Flentje M, Griesinger F, Niederle N, Stuschke M, Blum T, Deppermann KM, et al. Prevention, diagnosis, therapy, and follow-up of lung cancer. Pneumologie 2010, 64(Suppl 2):e1-e164.
3. de Jong WK, Schaapveld M, Blaauwgeers JLG, Groen HJM. Pulmonary tumours in the Netherlands: focus on temporal trends in histology and stage and on rare tumours. Thorax 2008, 63:1096-1102. 10.1136/thx.2007.095067, 18678702.
4. Non-small Cell Lung Cancer Collaborative G Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. Br Med J 1995, 311:899-909. Non-small Cell Lung Cancer Collaborative G.
5. Spiro SG, Rudd RM, Souhami RL, Brown J, Fairlamb DJ, Gower NH, Maslove L, Milroy R, Napp V, Parmar MKB, et al. Chemotherapy versus supportive care in advanced non-small cell lung cancer: improved survival without detriment to quality of life. Thorax 2004, 59:828-836. 10.1136/thx.2003.020164, 1746842, 15454647.
6. Roszkowski K, Pluzanska A, Krzakowski M, Smith AP, Saigi E, Aasebo U, Parisi A, Tran NP, Olivares R, Berille J. A multicenter, randomized, phase III study of docetaxel plus best supportive care versus best supportive care in chemotherapy-naive patients with metastatic or non-resectable localized non-small cell lung cancer (NSCLC). Lung Cancer 2000, 27:145-157. 10.1016/S0169-5002(00)00094-5, 10699688.
7. Langendijk JA, Aaronson NK, de Jong JMA, ten Velde GPM, Muller MJ, Lamers RJ, Slotman BJ, Wouters EFM. Prospective study on quality of life before and after radical radiotherapy in non-small-cell lung cancer. J Clin Oncol 2001, 19:2123-2133.
8. Hanna N, Shepherd FA, Fossella FV, Pereira JR, De Marinis F, von Pawel J, Gatzemeier U, Tsao TCY, Pless M, Muller T, et al. Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy. J Clin Oncol 2004, 22:1589-1597. 10.1200/JCO.2004.08.163, 15117980.
9. Speiser B, Spratling L. Intermediate dose-rate remote afterloading brachytherapy for intraluminal control of bronchogenic-carcinoma. Int J Radiat Oncol Biol Phys 1990, 18:1443-1448. 10.1016/0360-3016(90)90320-J, 1695215.
10. Mehta M, Shahabi S, Jarjour N, Steinmetz M, Kubsad S. Effect of endobronchial radiation-therapy on malignant bronchial obstruction. Chest 1990, 97:662-665. 10.1378/chest.97.3.662, 2306968.
11. Gauwitz M, Ellerbroek N, Komaki R, Putnam JB, Ryan MB, Decaro L, Davis M, Cundiff J. High-dose endobronchial irradiation in recurrent Bronchogenic-carcinoma. Int J Radiat Oncol Biol Phys 1992, 23:397-400. 10.1016/0360-3016(92)90759-B, 1587762.
12. Kubaszewska M, Skowronek J, Chichel A, Kanikowski M. The use of high dose rate endobronchial brachytherapy to palliate symptomatic recurrence of previously irriadiated lung cancer. Neoplasma 2008, 55:239-245.
13. Taulelle M, Chauvet B, Vincent P, Felix-Faure C, Buciarelli B, Garcia R, Brewer Y, Reboul F. High dose rate endobronchial brachytherapy: results and complications in 189 patients. Eur Respir J 1998, 11:162-168. 10.1183/09031936.98.11010162, 9543287.
14. Kelly JF, Delclos ME, Morice RC, Huaringa A, Allen PK, Komaki R. High-dose-rate endobronchial brachytherapy effectively palliates symptoms due to airway tumors: The 10-year M, D. Anderson Cancer Center experience. Int J Radiat Oncol Biol Phys 2000, 48:697-702. 10.1016/S0360-3016(00)00693-3, 11020566.
15. Anacak Y, Mogulkoc N, Ozkok S, Goksel T, Haydaroglu A, Bayindir U. High dose rate endobronchial brachytherapy in combination with external beam radiotherapy for stage III non-small cell lung cancer. Lung Cancer 2001, 34:253-259. 10.1016/S0169-5002(01)00249-5, 11679184.
16. Macha HN, Wahlers B, Reichle C, Vonzwehl D. Endobronchial radiation-therapy for obstructing malignancies - 10 years experience with ir-192 high-dose radiation brachytherapy afterloading technique in 365 patients. Lung 1995, 173:271-280.
17. Stout R, Barber P, Burt P, Hopwood P, Swindell R, Hodgetts J, Lomax L. Clinical and quality of life outcomes in the first United Kingdom randomized trial of endobronchial brachytherapy (intraluminal radiotherapy) vs. external beam radiotherapy in the palliative treatment of inoperable non-small cell lung cancer. Radiother Oncol 2000, 56:323-327. 10.1016/S0167-8140(00)00252-8, 10974381.
18. Chella A, Ambrogi MC, Ribechini A, Mussi A, Fabrini MG, Silvano G, Cionini L, Angeletti CA. Combined Nd-YAG laser/HDR brachytherapy versus Nd-YAG laser only in malignant central airway involvement: a prospective randomized study. Lung Cancer 2000, 27:169-175. 10.1016/S0169-5002(99)00102-6, 10699690.
19. Aygun C, Weiner S, Scariato A, Spearman D, Stark L. Treatment of non-small-cell lung-cancer with external beam radiotherapy and high-dose rate brachytherapy. Int J Radiat Oncol Biol Phys 1992, 23:127-132. 10.1016/0360-3016(92)90551-R, 1315311.
20. Huber RM, Fischer R, Hautmann H, Pöllinger B, Häussinger K, Wendt T. Does additional brachytherapy improve the effect of external irradiation? A prospective, randomized study in central lung tumors. Int J Radiat Oncol Biol Phys 1997, 38:533-540. 10.1016/S0360-3016(97)00008-4, 9231677.
21. Perol M, Caliandro R, Pommier P, Malet C, Montbarbon X, Carrie C, Ardiet JM. Curative irradiation of limited endobronchial carcinomas with high-dose rate brachytherapy - Results of a pilot study. Chest 1997, 111:1417-1423. 10.1378/chest.111.5.1417, 9149603.
22. Gollins SW, Ryder WDJ, Burt PA, Barber PV, Stout R. Massive haemoptysis death and other morbidity associated with high dose rate intraluminal radiotherapy for carcinoma of the bronchus. Radiother Oncol 1996, 39:105-116. 10.1016/0167-8140(96)01731-8, 8735477.
23. Huber RM, Fischer R, Hautmann H, Pöllinger B, Wendt T, Müller-Wening D, Häussinger K. Palliative endobronchial brachytherapy for central lung-tumors - a prospective, randomized comparison of 2 fractionation schedules. Chest 1995, 107:463-470. 10.1378/chest.107.2.463, 7531132.
24. The world-health-organization histological typing of lung-tumors. Am J Clin Pathol 1982, 77:123-136.
25. Kaplan EL, Meier P. Nonparametric-estimation from incomplete observations. J Am Stat Assoc 1958, 53:457-481.